110 related articles for article (PubMed ID: 28982309)
1. TWIST mediates resistance to paclitaxel by regulating Akt and Bcl-2 expression in gastric cancer cells.
Kwon CH; Park HJ; Choi Y; Won YJ; Lee SJ; Park DY
Tumour Biol; 2017 Oct; 39(10):1010428317722070. PubMed ID: 28982309
[TBL] [Abstract][Full Text] [Related]
2. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells.
Zhang X; Wang Q; Ling MT; Wong YC; Leung SC; Wang X
Int J Cancer; 2007 May; 120(9):1891-8. PubMed ID: 17230521
[TBL] [Abstract][Full Text] [Related]
3. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
5. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer.
Mortenson MM; Galante JG; Gilad O; Schlieman MG; Virudachalam S; Kung HJ; Bold RJ
J Cell Biochem; 2007 Dec; 102(5):1171-9. PubMed ID: 17960583
[TBL] [Abstract][Full Text] [Related]
6. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.
Zhang H; Gong J; Kong D; Liu HY
World J Gastroenterol; 2015 Mar; 21(10):2926-36. PubMed ID: 25780290
[TBL] [Abstract][Full Text] [Related]
8. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
9. Activator protein-1 involvement in proliferation inhibition by gene silencing of Twist in gastric cancer cells.
Luo GQ; Li JH; Cao L; Zhou YH; Wen JF
Pathology; 2011 Dec; 43(7):697-701. PubMed ID: 22002117
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.
Ferlini C; Raspaglio G; Mozzetti S; Distefano M; Filippetti F; Martinelli E; Ferrandina G; Gallo D; Ranelletti FO; Scambia G
Mol Pharmacol; 2003 Jul; 64(1):51-8. PubMed ID: 12815160
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
Page C; Lin HJ; Jin Y; Castle VP; Nunez G; Huang M; Lin J
Anticancer Res; 2000; 20(1A):407-16. PubMed ID: 10769688
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
Wang S; Huang X; Lee CK; Liu B
Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.
Wang X; Ling MT; Guan XY; Tsao SW; Cheung HW; Lee DT; Wong YC
Oncogene; 2004 Jan; 23(2):474-82. PubMed ID: 14724576
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression.
Hsu KW; Hsieh RH; Huang KH; Fen-Yau Li A; Chi CW; Wang TY; Tseng MJ; Wu KJ; Yeh TS
Carcinogenesis; 2012 Aug; 33(8):1459-67. PubMed ID: 22581828
[TBL] [Abstract][Full Text] [Related]
15. Overcoming paclitaxel resistance in lung cancer cells via dual inhibition of stathmin and Bcl-2.
Han ZX; Wang HM; Jiang G; Du XP; Gao XY; Pei DS
Cancer Biother Radiopharm; 2013 Jun; 28(5):398-405. PubMed ID: 23496232
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.
Kwok WK; Ling MT; Lee TW; Lau TC; Zhou C; Zhang X; Chua CW; Chan KW; Chan FL; Glackin C; Wong YC; Wang X
Cancer Res; 2005 Jun; 65(12):5153-62. PubMed ID: 15958559
[TBL] [Abstract][Full Text] [Related]
17. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
[TBL] [Abstract][Full Text] [Related]
18. Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.
Wu YH; Huang YF; Chang TH; Chou CY
Int J Cancer; 2017 Dec; 141(11):2305-2317. PubMed ID: 28815582
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
20. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway.
Chang MC; Chen CA; Hsieh CY; Lee CN; Su YN; Hu YH; Cheng WF
Biochem J; 2009 Dec; 424(3):449-58. PubMed ID: 19747165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
